Oyster mushroom mycelium grown on rice, offering beta-glucans and lovastatin-related compounds for immune and cholesterol support. Provides beta-glucans that prime your innate immune system to respond faster to threats
Reviewed March 2026
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Oyster Mushroom Mycelium has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
The immune-relevant polysaccharide of Pleurotus ostreatus is a beta-1,3/1,6-glucan of the same structural class as isolated fungal and yeast beta-glucans. Combining the two adds the same receptor-binding structure from two sources. Whole biomass delivers the glucan inside an intact cell wall, an isolate delivers it already freed.
Saccharomyces-derived beta-1,3/1,6-glucan shares the branched backbone recognised by dectin-1 on innate immune cells with the mushroom glucan. Yeast material is typically purified to a defined glucan percentage while mycelial biomass is not. The pairing is structural overlap, not a tested combination.
Oat beta-glucan is a linear beta-1,3/1,4 polysaccharide, a different linkage pattern from the branched fungal glucan, and it behaves as a viscous fermentable fibre rather than a dectin-1 ligand. Naming both on one label is only honest if the difference is stated. They share a word, not a mechanism.
Grain-grown mycelial biomass is mycelium plus the colonised substrate, so a meaningful share of the finished powder is residual rice starch. Amylase digests that starch fraction; it does nothing to the fungal cell wall. This is worth saying plainly because starch content is what separates a biomass powder from a fruiting body extract.
Fungal cell walls are chitin and glucan, and human digestive enzymes do not break chitin, which is why hot-water extraction rather than enzyme support is the usual way to free mushroom polysaccharides. Enzyme blends act mainly on the starch and protein travelling with the biomass. The limit here is the wall, not the gut.
Fungal beta-glucans that escape digestion are fermented by colonic bacteria to short-chain fatty acids including butyrate. Supplying butyrate directly and supplying a fermentable substrate reach the same colonocyte fuel by different routes. Fermentability varies with how much of the glucan is still locked in chitin.
Inulin is a readily fermented fructan and fungal glucan a slower, more structured substrate, so the two are fermented by different bacterial groups at different rates along the colon. Formulators pair fast and slow substrates for that reason. No combination trial covers this specific pairing.
Live cultures need fermentable carbohydrate to establish, and undigested fungal polysaccharide is one such substrate. The pairing is the standard synbiotic logic. Which strains actually use fungal glucan is strain-specific and not settled.
Ergothioneine, a thiol-bearing antioxidant that mushrooms including Pleurotus accumulate, is built from histidine by fungal biosynthesis: the imidazole ring is trimethylated and a sulfur is added from cysteine. Histidine is the ring donor. This explains where the compound comes from and is not a reason to take the two together.
The sulfur atom in fungal ergothioneine is transferred from cysteine during biosynthesis in the mycelium. This is fungal metabolism happening before harvest, not an interaction in the person taking it. It is included because ergothioneine content is one of the things that distinguishes mushroom material.
Mushroom tissue contains ergosterol, which ultraviolet light converts to ergocalciferol, vitamin D2. Biomass grown indoors without UV exposure carries little of it, so the vitamin D on a mushroom label comes from a deliberate UV step or from added vitamin D. The chemistry is settled; whether a given batch had UV exposure is a manufacturing fact.
Multi-mushroom blends put Pleurotus alongside Ganoderma because their polysaccharide fractions differ in branching and molecular weight. The pairing is formulation convention with a shared polysaccharide rationale. Blend-level evidence is thinner than single-species evidence.
Trametes versicolor supplies protein-bound polysaccharides, a structurally distinct fungal glucan class from the Pleurotus material. Blends combine them to widen the polysaccharide profile. The rationale is compositional rather than clinical.
Hericium is the other species most often grown as grain-based mycelial biomass, and the same manufacturing questions apply to both: how much of the powder is fungus and how much is substrate. Pairing them is a category convention. Read it as formulation practice.
Ascorbate is water soluble and works in the aqueous phase alongside the thiol antioxidants that mushroom tissue carries, including ergothioneine. The two sit in overlapping compartments. This is antioxidant chemistry, not a measured outcome for the combination.
Mushrooms concentrate minerals from their substrate, and selenium content in cultivated material tracks what the substrate contained. Rice-based substrate is generally low in it. The practical point is that mineral content of biomass is a substrate fact, so a formula supplies selenium separately rather than relying on the mushroom.
Talk to a doctor before taking Oyster Mushroom Mycelium if any of these apply to you: Mycelium on grain has low mushroom content, Lovastatin amounts are tiny vs prescription doses, May interact with statin medications. These are flags to check first, not effects Oyster Mushroom Mycelium is known to cause.
Not medical advice. Show the label to your pharmacist.The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
These are the studies our verdict leans on, chosen from the 8 we read for Oyster Mushroom Mycelium. The full linked list is below.
1 source behind our Oyster Mushroom Mycelium verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.